tirzepatide vs retatrutide vs semaglutide Compared Tirzepatide vs. Retatrutide: Key Differences

Approximately 4 to 5 million Americans are now using GLP-1 receptor agonist medications for weight loss, representing one of the fastest adoption rates for any new weight management therapy in the past two decades

Peer-reviewed research published in journals including the New England Journal of Medicine has demonstrated statistically significant weight loss outcomes with semaglutide and tirzepatide in large randomized controlled trials involving thousands of participants tracked over periods of 68 weeks or longer

I have also heard of its use quite successfully for fibromyalgia, endometriosis, interstitial cystitis, and most other conditions where the final common pathway is chronic pain

Johnson, B

Affordable Affordable appointments, prescriptions, and lab testing so you can stay on top of your health